COMPASS Pathways presents largest ever study of psilocybin
Positive data from phase IIb study shows potential of COMP360 psilocybin therapy in treatment-resistant depression London, UK – 23 May...
Source: globenewswire.com
Page 30 - Guy Goodwin News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Guy Goodwin. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Guy Goodwin Today - Breaking & Trending Today
King's College London: New Study To Evaluate Psilocybin's Therapeutic Potential On Autistic Adults – India Education | Latest Education News | Global Educational News
A new study, led by researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King's College London will explore the potential therapeutic effects of psilocybin on autistic adults.The study will explore how psilocybin aff
Source: indiaeducationdiary.in
COMPASS Pathways plc (CMPS) Q1 2022 Earnings Call Transcript
CMPS earnings call for the period ending March 31, 2022.
Source: fool.com
Investegate |COMPASS Pathways Announcements | COMPASS Pathways: COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
Investegate announcements from COMPASS Pathways, COMPASS Pathways to fund study of COMP360 psilocybin in autistic adults
Source: investegate.co.uk
Thomas Insel and the Future of the Mental Health System
Insel says he has the answer—the same emphasis on neuroscience and genetics, which he admits led to no improvements under his leadership.
Source: madinamerica.com